D70.0

Clinical Causes: C o n g e n i t a l a g r a n u l o c y t o s i s i s c a u s e d b y g e n e t i c m u t a t i o n s t h a t a f f e c t t h e p r o d u c t i o n a n d d e v e l o p m e n t o f g r a n u l o c y t e s . T h e s e m u t a t i o n s a r e u s u a l l y i n h e r i t e d i n a n a u t o s o m a l d o m i n a n t o r r e c e s s i v e m a n n e r , m e a n i n g t h e y c a n b e p a s s e d f r o m p a r e n t t o c h i l d . T h e p r i m a r y g e n e i n v o l v e d i s l i n k e d t o t h e p a t h w a y s r e s p o n s i b l e f o r t h e d e v e l o p m e n t o f m y e l o i d c e l l s , i n c l u d i n g n e u t r o p h i l s . T h e c o n d i t i o n m a n i f e s t s e a r l y i n l i f e , o f t e n d e t e c t a b l e d u r i n g i n f a n c y o r e a r l y c h i l d h o o d .

Key Symptoms: C h i l d r e n b o r n w i t h c o n g e n i t a l a g r a n u l o c y t o s i s m a y n o t s h o w i m m e d i a t e s i g n s ; h o w e v e r , t y p i c a l s y m p t o m s a s t h e i m m u n e s y s t e m b e c o m e s c o m p r o m i s e d i n c l u d e : - F r e q u e n t b a c t e r i a l i n f e c t i o n s s u c h a s p n e u m o n i a , s k i n a b s c e s s e s , o r m o u t h u l c e r s . - R e c u r r e n t f e v e r s o r c h i l l s . - P e r s i s t e n t s o r e t h r o a t s . - U l c e r s i n t h e m o u t h o r t h r o a t . - P o o r w o u n d h e a l i n g . - I n c r e a s e d s u s c e p t i b i l i t y t o o t h e r i n f e c t i o n s . - S i g n s o f i n f e c t i o n m a y d e v e l o p r a p i d l y a n d c a n b e c o m e s e v e r e i f n o t m a n a g e d p r o m p t l y .

Diagnosis Path: Diagnosis is usually made through a combination of blood tests and genetic analysis: - Complete blood counts (CBC) reveal a significant decrease in neutrophil counts. - Bone marrow biopsies may show reduced myeloid cell production. - Genetic testing can identify mutations responsible for the disorder. - Clinical history and family background are considered to understand inheritance patterns. Early diagnosis is crucial in managing and preventing severe infections associated with low neutrophil levels.

Treatment Protocols: Managing congenital agranulocytosis primarily involves strategies to prevent and treat infections and support immune function: - Regular administration of granulocyte colony-stimulating factor (G-CSF) to stimulate neutrophil production. - Antibiotics and antifungal medications to treat and prevent infections. - Strict hygiene practices and avoiding exposure to infectious agents. - Monitoring blood counts regularly to assess treatment efficacy. - In some severe cases, hematopoietic stem cell transplantation may be considered. While G-CSF therapy has significantly improved outcomes, ongoing medical supervision is necessary to manage potential complications and infections.